Abiotrophia bacteremia in a patient with neutropenic fever and antimicrobial susceptibility testing of Abiotrophia isolates.
We report a case of bacteremia due to Abiotrophia species in a patient with neutropenic fever and cancer who was receiving levofloxacin prophylaxis, followed by empirical therapy with cefepime; the organism was resistant to both antibiotics. We provide susceptibility data on 20 additional bloodstream isolates of Abiotrophia species.
Murray
C K
CK
Department of Medicine, Infectious Diseases Service, Brooke Army Medical Center, Fort Sam Houston, TX 78234-6200, USA. Clinton.Murray@CEN.AMEDD.ARMY.MIL
Walter
E A
EA
Crawford
S
S
McElmeel
M L
ML
Jorgensen
J H
JH
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D016470:Bacteremia / Q000382:microbiology*; D000077723:Cefepime; D002511:Cephalosporins / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D005334:Fever / Q000209:etiology; D016908:Gram-Positive Bacterial Infections / Q000382:microbiology*; D006801:Humans; D064704:Levofloxacin; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D009503:Neutropenia / Q000150:complications*; D015242:Ofloxacin / Q000494:pharmacology; D013289:Streptococcaceae / Q000187:drug effects*
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D064704:Levofloxacin; D000077723:Cefepime; D015242:Ofloxacin